|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3750 AUD | -1.32% |
|
+2.74% | -42.31% |
| 30/07 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 21/07 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.4 | 0.47 | 0.475 |
| Spread/Res. | -6.25% | -20.21% | -21.05% |
| Spread/Supp. | +7.14% | +7.14% | +4.17% |
| Support | 0.35 | 0.35 | 0.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RCE Stock
- Charts Recce Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
